Effects of systemic inflammation on endothelium-dependent vasodilation

Trends in Cardiovascular Medicine

Volumn 16, Issue 1, 2006, Pages 15-20

  Huang, Alex L ^a   Vita, Joseph A ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN SYNTHASE INHIBITOR; SALMONELLOSIS VACCINE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; EXERCISE; HOMEOSTASIS; HUMAN; INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; VASCULAR ENDOTHELIUM; VASODILATATION;

ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; NITRIC OXIDE; VASODILATION;

EID: 29444439974     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.10.002     Document Type: Review

References (42)

1. JL Anderson Infection, antibiotics, and atherothrombosis-end of the road or new beginnings? N Engl J Med 352 2005 1706 1709
2. CM Ballantyne, J Houri, and A Notarbartolo Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial Circulation 107 2003 2409 2415
3. K Bhagat, R Moss, J Collier, and P Vallance Endothelial "stunning" following a brief exposure to endotoxin: A mechanism to link infection and infarction? Cardiovasc Res 32 1996 822 829
4. PO Bonetti, LO Lerman, C Napoli, and A Lerman Statin effects beyond lipid lowering-are they clinically relevant? Eur Heart J 24 2003 225 248
5. G Brevetti, VD Martone, and T De Cristofaro High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease Thromb Haemost 85 2001 63 66
6. G Brevetti, A Silvestro, and S Di Giacomo Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden J Vasc Surg 38 2003 374 379
7. MC Corretti, TJ Anderson, and EJ Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
8. SF Davis, AC Yeung, and IT Meredith Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant Circulation 93 1996 457 462
9. SE Epstein, J Zhu, and MS Burnett Infection and atherosclerosis: Potential roles of pathogen burden and molecular mimicry Arterioscler Thromb Vasc Biol 20 2000 1417 1420
10. S Fichtlscherer, G Rosenberger, and DH Walter Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease Circulation 102 2000 1000 1006
11. S Fichtlscherer, L Rossig, and S Breuer Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure Circulation 104 2001 3023 3025
12. JM Hill, G Zalos, and JP Halcox Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 2003 593 600
13. AD Hingorani, J Cross, and RK Kharbanda Acute systemic inflammation impairs endothelium-dependent dilatation in humans Circulation 102 2000 994 999
14. A Holmlund, J Hulthe, and J Millgard Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals Atherosclerosis 165 2002 271 276
15. D Hurlimann, A Forster, and G Noll Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2002 2184 2187
16. S Husain, NP Andrews, and D Mulcahy Aspirin improves endothelial dysfunction in atherosclerosis Circulation 97 1998 716 720
17. RK Kharbanda, B Walton, and M Allen Prevention of inflammation-induced endothelial dysfunction: A novel vasculo-protective action of aspirin Circulation 105 2002 2600 2604
18. JT Kuvin, N Gokce, and M Holbrook Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function Am J Cardiol 91 2003 732 735
19. JT Kuvin, AR Patel, and KA Sliney Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude Am Heart J 146 2003 168 174
20. P Libby, PM Ridker, and A Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
21. GF Mitchell, H Parise, and JA Vita Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study Hypertension 44 2004 134 139
22. C Monaco, and E Paleolog Nuclear factor kappaB: A potential therapeutic target in atherosclerosis and thrombosis Cardiovasc Res 61 2004 671 682
23. JJ Oliver, and DJ Webb Noninvasive assessment of arterial stiffness and risk of atherosclerotic events Arterioscler Thromb Vasc Biol 23 2003 554 566
24. TA Pearson, GA Mensah, and RW Alexander Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
25. MB Pepys CRP or not CRP? That is the question Arterioscler Thromb Vasc Biol 25 2005 1091 1094
26. J Pleiner, G Schaller, and F Mittermayer Simvastatin prevents vascular hyporeactivity during inflammation Circulation 110 2004 3349 3354
27. A Prasad, J Zhu, and JP Halcox Predisposition to atherosclerosis by infections: Role of endothelial dysfunction Circulation 106 2002 184 190
28. PM Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
29. R Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
30. J Sinisalo, J Paronen, and KJ Mattila Relation of inflammation to vascular function in patients with coronary heart disease Atherosclerosis 149 2000 403 411
31. R Stocker, and JF Keaney The role of oxidative modifications in atherosclerosis Physiol Rev 84 2004 1381 1478
32. KC Tan, WS Chow, and SC Tam Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus J Clin Endocrinol Metab 87 2002 563 568
33. H Teragawa, Y Fukuda, and K Matsuda Relation between C reactive protein concentrations and coronary microvascular endothelial function Heart 90 2004 750 754
34. F Tomai, F Crea, and A Gaspardone Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion Circulation 104 2001 1471 1476
35. P Vallance, J Collier, and K Bhagat Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link? Lancet 349 1997 1391 1392
36. S Verma, CH Wang, and SH Li A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919
37. S Verma, CH Wang, and E Lonn Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals Eur Heart J 25 2004 1754 1760
38. JA Vita Nitric oxide-dependent vasodilation in human subjects Methods Enzymol 359 2002 186 200
39. JA Vita, JF Keaney, and MG Larson Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study Circulation 110 2004 3604 3609
40. ME Widlansky, N Gokce, JF Keaney, and JA Vita The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 2003 1149 1160
41. ME Widlansky, DT Price, and N Gokce Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension Hypertension 42 2003 310 315
42. DR Witte, WM Broekmans, and AF Kardinaal Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other Atherosclerosis 170 2003 147 153